GH Research PLC Competitors
Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
---|---|---|---|---|---|---|
ANEB
|
Anebulo Pharmaceuticals, Inc. | $1.59 | $56.28 M | -5.86 | 2 | $0 |
ANNX
|
Annexon, Inc. | $6.12 | $523.15 M | -3.93 | 71 | $0 |
CGEM
|
Cullinan Oncology, Inc. | $13.86 | $1.29 B | -7.16 | 85 | $0 |
CSBR
|
Champions Oncology, Inc. | $4.50 | $62.53 M | -6.39 | 210 | $50.16 M |
CYT
|
Cyteir Therapeutics, Inc. | $3.02 | $108.71 M | -3.25 | 46 | $0 |
DSGN
|
Design Therapeutics, Inc. | $5.80 | $217.51 M | -3.7 | 54 | $0 |
ELYM
|
Eliem Therapeutics, Inc. | $5.11 | $258.33 M | -17.08 | 9 | $0 |
GLUE
|
Monte Rosa Therapeutics, Inc. | $7.74 | $243.38 M | -1.59 | 133 | $0 |
GPCR
|
Structure Therapeutics Inc. | $34.17 | $2.47 B | -23.59 | 136 | $0 |
HOWL
|
Werewolf Therapeutics, Inc. | $1.77 | $151.66 M | -3.17 | 45 | $19.94 M |
IKNA
|
Ikena Oncology, Inc. | $1.69 | $84.45 M | -1.11 | 14 | $9.16 M |
JANX
|
Janux Therapeutics, Inc. | $48.76 | $2.29 B | -36.8 | 76 | $8.08 M |
MLYS
|
Mineralys Therapeutics, Inc. | $11.48 | $652.38 M | -6.03 | 28 | $0 |
MNOV
|
MediciNova, Inc. | $1.86 | $67.19 M | -8.06 | 13 | $1.00 M |
MOLN
|
Molecular Partners AG | $5.31 | $135.05 M | -2.03 | 167 | $7.04 M |
PEPG
|
PepGen Inc. | $4.12 | $537.15 M | -5.11 | 76 | $0 |
PHVS
|
Pharvaris N.V. | $20.35 | $843.31 M | -5.8 | 83 | $0 |
PMVP
|
PMV Pharmaceuticals, Inc. | $1.61 | $85.40 M | -1.26 | 63 | $0 |
RCUS
|
Arcus Biosciences, Inc. | $15.71 | $1.41 B | -4.98 | 577 | $117.00 M |
RLAY
|
Relay Therapeutics, Inc. | $5.11 | $1.05 B | -3 | 294 | $25.55 M |
RZLT
|
Rezolute, Inc. | $5.29 | $229.57 M | -5.02 | 59 | $0 |
STOK
|
Stoke Therapeutics, Inc. | $12.03 | $774.50 M | -6.14 | 110 | $8.78 M |